欧州脊髄損傷治療市場
Market Size in USD Billion
CAGR :
% 
USD
2.13 Billion
USD
3.01 Billion
2024
2032
 予測期間 |
2025 –2032 |
 市場規模（基準年） |
USD 2.13 Billion |
 Market Size (Forecast Year) |
USD 3.01 Billion |
 CAGR |
% |
| Major Markets Players |
|
欧州脊髄損傷治療市場：タイプ別（非手術的管理および手術的管理）、損傷タイプ別（完全脊髄損傷および部分脊髄損傷）、損傷レベル別（頸部脊髄損傷、胸部脊髄損傷、腰部脊髄損傷、仙骨脊髄損傷）、性別別（男性および女性）、エンドユーザー別（病院、外傷センター、専門クリニック、診療所、外来・研究センター、その他） - 2032年までの業界動向および予測
欧州脊髄損傷治療市場分析
2021年5月にInternational Journal of Health Policy and Managementに掲載された記事によると、脊髄損傷（SCI）の健康研究分野においてパートナーシップアプローチがますます普及しており、SCI研究パートナーシップのリーダーの成功事例を探求し、そこから学ぶ機会が生まれています。欧州の脊髄損傷治療市場における連携の拡大とパートナーシップの拡大は、イノベーションの推進、研究の進歩、そして患者ケアの向上に極めて重要です。多様な分野の専門知識を組み合わせることで、これらの連携は革新的な治療法の開発を促進し、リハビリテーション技術を向上させ、医療機器の改良につながります。
欧州脊髄損傷治療市場規模
欧州の脊髄損傷治療市場は、2024年の21億3,000万米ドルから2032年には30億1,000万米ドルに達し、2025年から2032年の予測期間に4.4%のCAGRで成長すると予想されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、データブリッジ市場調査がまとめた市場レポートには、輸出入分析、生産能力概要、生産消費分析、価格動向分析、気候変動シナリオ、サプライチェーン分析、バリューチェーン分析、原材料/消耗品概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制枠組みも含まれています。
欧州脊髄損傷治療市場動向
「成長するコラボレーションと拡大するパートナーシップ」
脊髄損傷（SCI）研究の発展分野において、注目すべき傾向として、学術機関、研究機関、製薬会社、医療機器メーカー間の連携が拡大しています。これらの連携により、再生能力の限界や治療の複雑さといったSCI固有の課題に取り組むための専門知識、リソース、資金の共有が促進されます。多様な強みを結集することで、これらのパートナーシップは幹細胞治療、神経補綴、遺伝子治療といった革新的な治療法の開発を加速させています。さらに、業界の関係者はリハビリテーションプログラムの強化、移動補助具の改良、診断ツールの改善に協力しています。新たな傾向として、臨床データの共同共有が挙げられます。これはSCIの病態生理学への理解を深め、個々の患者に合わせた治療戦略の策定に役立ちます。さらに、欧州の医療提供者と政策立案者間の連携は、最先端の治療へのアクセスを向上させ、その費用対効果を確保する改革を推進しています。全体として、こうした協力的な傾向は、治療の水準を高めるだけでなく、脊髄損傷を治療するための世界的な取り組みを推進し、最終的には患者たちの生活を変えることになります。
レポートの範囲と欧州脊髄損傷治療市場のセグメンテーション
|
属性 |
欧州脊髄損傷治療市場の洞察 |
|
対象セグメント |
|
|
対象地域 |
ドイツ、イギリス、フランス、ロシア、イタリア、スペイン、トルコ、ポーランド、オランダ、スイス、ノルウェー、オーストリア、アイルランド、その他のヨーロッパ諸国 |
|
主要な市場プレーヤー |
ノバルティスAG（スイス）、ファイザー社（米国）、メドトロニック社（アイルランド）、ジンマー・バイオメット社（米国）、アボット社（米国）、アムニール・ファーマシューティカルズLLC（米国）、サノフィ社（フランス）、アクソニス・セラピューティクス社（米国）、ザイダス・グループ社（インド）、リネージ・セル・セラピューティクス社（米国）、サン・ファーマシューティカル・インダストリーズ社（インド）、キャンバー・ファーマシューティカルズ社（米国）、ドクター・レディーズ・ラボラトリーズ社（インド）、テバ・ファーマシューティカルズUS社（イスラエル）、ニクサン・ファーマシューティカルズ社（インド）、コヴィス・ファーマ社（スイス）、インディアン・スピナル・インジュリーズ・センター社（インド）、ジュビラント・カディスタ・ファーマシューティカルズ社（米国）、ジョンソン・エンド・ジョンソン社（米国）、ナーヴジェン・ファーマ社（カナダ）、アドバケア・ファーマ社（米国）、ボストン・サイエンティフィック社（米国）、ヴァスダ・ファーマ社（インド）、エノマーク社（インド）、グレンマーク・ファーマシューティカルズUS社（米国）、イノバPharmaceuticals（オーストラリア）、Globus Medical（米国）、Zimvie Inc.（米国）、Bioaxone（カナダ） |
|
市場機会 |
|
|
付加価値データ情報セット |
データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、輸出入分析、生産能力概要、生産消費分析、価格動向分析、気候変動シナリオ、サプライチェーン分析、バリューチェーン分析、原材料/消耗品概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制枠組みも含まれています。 |
欧州脊髄損傷治療市場の定義
脊髄損傷の治療とは、脊髄損傷に伴う機能、運動機能、感覚の喪失を様々な程度で抑えることを目的とした、幅広い医療介入とリハビリテーション戦略を指します。治療アプローチには、脊椎を安定させるための外科手術、疼痛管理と炎症軽減のための薬物療法、そして患者の自立と生活の質の向上を支援する理学療法や作業療法などの療法が含まれます。さらに、研究の進歩により、幹細胞療法などの再生医療技術や、回復を促進し適応機能をサポートする支援技術の開発が進む可能性があります。脊髄損傷治療の全体的な目標は、回復成果を最適化し、機能的リハビリテーションを促進し、患者の全体的な健康状態を改善することです。
欧州脊髄損傷治療市場の動向
ドライバー
- 協力関係の拡大とパートナーシップの拡大
SCI研究が進展するにつれ、学術機関、研究機関、製薬会社、医療機器メーカー間の連携がますます重要になっています。これらの連携により、専門知識、リソース、資金を結集し、再生能力の限界や治療の複雑さなど、脊髄損傷に伴う重大な課題を克服することが可能になります。こうした連携を通じて、幹細胞治療、神経補綴、遺伝子治療といった革新的な治療法の開発が加速しています。さらに、業界関係者は、より効果的なリハビリテーションプログラムの開発、移動補助具などの医療機器の改良、より優れた診断ツールの確立に向けて協力しています。連携の拡大は、SCIの病態生理学への理解を深め、個別化された治療戦略を最適化するために不可欠な臨床データを共有するためのプラットフォームも提供します。さらに、欧州の医療提供者と政策立案者間の連携は、医療改革の推進、最先端治療へのアクセス向上、そしてSCI治療の経済的負担の軽減に貢献しています。最終的には、こうしたパートナーシップの拡大により、ケアの質が向上するだけでなく、脊髄損傷の治療法を見つけるヨーロッパの取り組みにも貢献し、イノベーションを推進し、世界中で脊髄損傷に苦しむ人々の生活を向上させます。
例えば、
- 2021年5月、国際保健政策管理ジャーナルに掲載された記事によると、パートナーシップアプローチは脊髄損傷（SCI）の健康研究分野でますます人気が高まっており、SCI研究パートナーシップのチャンピオンの成功を探求し、そこから学ぶ機会が生まれています。
- TechTarget Networkに掲載された記事によると、2023年5月、リーブ財団とアルバータ大学は、脊髄損傷研究におけるオープンデータ共有を促進し、価値、知識の共有、データの透明性を高めることを目指して提携しました。アルバータ大学とリーブ財団は、脊髄損傷のためのオープンデータコモンズ（ODC-SCI）を通じてオープンデータ共有を促進するための3年間の共同プロジェクトを開始しました。
- 欧州の脊髄損傷治療市場における連携の拡大とパートナーシップの拡大は、イノベーションの推進、研究の進展、そして患者ケアの向上に極めて重要です。多様な分野の専門知識を組み合わせることで、これらの連携は革新的な治療法の開発を促進し、リハビリテーション技術を向上させ、医療機器の改良につながります。その結果、脊髄損傷（SCI）の患者は、より効果的で個別化された治療とより良い転帰の恩恵を受けることができます。パートナーシップへの継続的な投資により、市場は脊髄損傷の治療と潜在的な治癒の両面で大きな進歩を遂げ、最終的には世界中の何百万人もの人々の生活の質を向上させることが期待されます。
治療法における技術的進歩
幹細胞療法、神経補綴、高度な神経刺激技術といったイノベーションは、脊髄損傷（SCI）患者の回復の見通しを大きく改善しています。ロボット外骨格や、個別化治療計画のための人工知能（AI）の開発は、リハビリテーションの成果を向上させています。さらに、脊髄再生のための生体材料やCRISPRなどの遺伝子編集技術の飛躍的進歩は、失われた機能の回復に新たな希望をもたらしています。これらの最先端治療は、治療効果を高めるだけでなく、より多くの患者が生活の質を向上させるための高度なソリューションを求めるにつれて、市場を拡大しています。
例えば、
- 2023年10月、NCBIが発表した論文によると、脊髄損傷（SCI）治療における技術進歩、例えばハイドロゲルのような柔軟な生体材料の開発は、組織修復における課題の解決に貢献しています。これらの材料は、損傷部の形状に適応し、線維化を防ぎ、軸索の成長を促進することで、脊髄再生をサポートします。
- 2021年7月、NCBIが発表した論文によると、硬膜外電気刺激（EES）などの脊髄損傷（SCI）治療における技術的進歩は、前臨床研究と臨床研究の両方で有望な結果を示しています。EESは脊髄損傷後の感覚機能と運動機能を向上させ、回復成果を向上させる可能性を示唆しています。この革新は、脊髄損傷（SCI）のリハビリテーションにおける電気刺激の役割の拡大を浮き彫りにしています。
- 技術の進歩は脊髄損傷治療の状況を一変させ、患者に新たな希望をもたらし、回復の成果を大幅に向上させています。幹細胞療法、神経補綴、神経刺激療法、そして人工知能を活用した個別化治療におけるイノベーションは、リハビリテーションの見通しを明るくしています。生体材料と遺伝子編集におけるブレークスルーは、脊髄再生の限界をさらに押し広げ、失われた機能を回復させ、生活の質を向上させています。これらの最先端治療が進化を続けるにつれ、脊髄損傷治療市場は成長し、より高度で効果的なソリューションを必要とする人々に提供していくでしょう。
制約/課題
- 脊髄治療の潜在的なリスク、副作用、合併症
脊髄損傷に対する現在の治療法には、外科的介入や薬物療法などがあり、さまざまな副作用、合併症、そして長期的なリスクを伴います。外科的処置は特定の損傷に対しては不可欠ですが、感染症、出血、あるいは周辺組織の損傷を引き起こす可能性があり、患者の状態をさらに悪化させる可能性があります。さらに、手術の結果として、麻痺や運動機能の喪失といった神経学的合併症が発生する可能性も常に存在します。薬物療法の場合、吐き気、めまい、鎮痛剤への依存といった副作用が回復過程を複雑にする可能性があります。より重篤な症例では、疼痛や炎症を抑えるために使用される薬物療法が、臓器障害や免疫抑制といった長期的な問題につながる可能性があります。これらのリスクは、特に健康状態の悪化や新たな合併症の発症を懸念する多くの患者が、これらの治療法の追求を躊躇させる要因となっています。その結果、一部の患者はこれらの治療を避けたり、遅らせたりして、十分な臨床試験が行われていない可能性のある代替療法や非従来的なアプローチを選択することがあります。こうした従来の治療法への抵抗は、最終的に患者の回復過程に影響を与え、改善の遅れや全体的な治療効果の低下につながる可能性があります。さらに、脊髄損傷（SCI）の生涯にわたる後遺症に苦しむ患者にとって、継続的な治療リスクや合併症の負担は、身体的および精神的な負担をさらに増大させ、治療を継続するという決断をさらに困難にする可能性があります。
例えば
- 2024年12月、NCBIが発表した論文によると、慢性または腫瘍性の脊髄損傷（SCI）は、持続的な腰痛、全身症状（体重減少、発熱、食欲不振）、進行性の感覚運動機能低下などの症状を呈することがあります。病変が拡大するにつれて、握力や運動機能の低下などの運動障害が現れることがあります。リスク要因としては、喫煙、過去の癌治療、結核への曝露、最近の手術、免疫抑制などが挙げられます。
- 2025年1月、NCBIが発表した論文によると、脊髄損傷（SCI）は、肺炎、循環障害、筋硬直、自律神経失調症、褥瘡、神経性疼痛、膀胱・腸障害、性機能障害、うつ病など、様々な合併症を引き起こす可能性があります。これらの問題に対処するには、患者は綿密なモニタリング、予防措置、そして薬物療法、理学療法、精神的サポートといった専門的な治療を必要とします。
外科的治療と薬物療法は脊髄損傷の回復に不可欠ですが、感染症、神経学的合併症、長期的な副作用など、大きなリスクを伴います。これらの潜在的な欠点は、患者がさらなる悪影響や生活の質の低下を恐れ、これらの治療の追求や完全な治療へのコミットメントを躊躇させる原因となることがよくあります。その結果、患者は代替療法に頼ることになりますが、必ずしも効果的とは限りません。これは、より安全で効果的な治療法の必要性を強調するものであり、脊髄損傷患者をより良くサポートするためには、潜在的なリスクと回復の可能性のバランスをとった包括的なケアを提供することの重要性を浮き彫りにしています。
- 脊髄損傷の治療に関する理解の不足
脊髄損傷（SCI）の複雑な病態生理に対する理解が不十分なため、効果的な治療法の開発が著しく阻害され、欧州のSCI治療市場にとって大きな課題となっています。SCIは分子レベルおよび細胞レベルで一連の事象を引き起こし、神経損傷、炎症、グリア瘢痕形成といった機能障害を引き起こします。これらの複雑なプロセスを完全に理解していないため、正確な治療標的を特定し、神経再生と機能回復を効果的に促進する介入を設計することが困難です。その結果、現在の多くの治療法は、SCIの根本原因への対処よりも、症状の管理と合併症の予防に重点を置いています。
例えば、
- 2020年10月、国立医学図書館に掲載された論文によると、脊髄損傷後の複雑な特徴、多くの矛盾、複雑な病態生理学的結果などの異質な要因が、脊髄損傷治療の理解不足と失敗の主な原因となっている。
- 2023年2月、オックスフォード大学出版局が発表した論文によると、脊髄損傷（SCI）の病態生理は複雑かつ多面的であるため、特定の側面やプロセスに作用する個別の治療法では、脊髄損傷後の神経再生や機能回復を促すには不十分である。
この知識ギャップは、個別化治療戦略の開発を阻害しています。SCIは均一な病態ではなく、個々の患者は損傷の重症度、神経障害、機能障害の程度が異なります。各患者の損傷を引き起こす具体的なメカニズムを徹底的に理解しなければ、個々のニーズに合わせた治療計画を策定することが困難になります。これは、最適な治療結果が得られず、患者満足度の低下につながる可能性があります。さらに、SCIに関する理解の不足は、正確な診断ツールやバイオマーカーの開発を妨げ、治療効果のモニタリングや長期的な転帰の予測を困難にしています。この課題を克服するには、SCIの複雑さを解明し、より効果的で標的を絞った治療法への道を開くため、基礎研究とトランスレーショナル研究への多大な投資が必要です。
機会
高齢化人口の増加
加齢に伴い、骨密度、筋力、バランス能力が低下することが多く、転倒しやすくなります。これは、この年齢層における脊髄損傷（SCI）の主な原因です。こうした年齢層の変化は、専門的な治療とリハビリテーションサービスを必要とする患者基盤の増加につながっています。負傷後の即時的なケアだけでなく、疼痛、痙縮、褥瘡など、継続的な医療ケアを必要とする脊髄損傷（SCI）関連の合併症の長期的な管理も求められています。
例えば、
- 2024年1月、Population Reference Bureau（人口参考局）が発表した記事によると、65歳以上のアメリカ人の数は2022年の5,800万人から2050年には8,200万人（47%増）に増加すると予測されており、65歳以上の人口が総人口に占める割合は17%から23%に上昇すると予測されています。脊椎損傷を起こしやすい高齢者人口の増加は、需要を押し上げ、脊椎損傷治療市場の拡大につながるでしょう。
- 2019年10月に米国国立医学図書館が発表した論文によると、研究の60%において、機能障害のレベル、機能的困難、日常生活動作、身体能力が特定されていました。このレビューは、高齢者における腰痛の有病率の高さと機能障害を示唆しています。
さらに、高齢者人口は脊髄損傷（SCI）治療において特有の課題を抱えることが多く、個々に合わせたアプローチと革新的なソリューションが求められます。高齢者は既往症を抱えている場合があり、治療計画を複雑にし、専門的なケア戦略が必要となることがあります。こうした状況から、年齢に応じた治療法や補助器具の研究開発が求められています。さらに、SCIの身体的側面への対応にとどまらず、高齢患者のメンタルヘルスサポート、社会統合、そして生活の質の向上にも焦点が当てられています。したがって、高齢者人口の増加は脊髄損傷（SCI）治療市場の成長と多様化を促進する触媒として機能し、関係者は高齢者のニーズに合わせた包括的なケアソリューションを革新的に提供することを迫られています。
外傷の発生率の上昇
自動車事故、転倒、スポーツ傷害、暴力などによる外傷は、世界の脊髄損傷（SCI）治療市場にとって大きなビジネスチャンスとなります。これらの事故の発生頻度が高まるにつれ、脊髄損傷を患う人の数も増加し、治療対象となる潜在的な患者基盤が拡大します。この傾向は、特に危険性の高い活動に従事する傾向にある若年層で顕著です。その結果、救急治療、外科的介入、リハビリテーションサービス、支援技術など、効果的かつ高度な治療オプションへの需要が高まり、SCI治療市場の成長を牽引しています。医療機器メーカー、製薬会社、医療機関は、外傷性SCI患者のニーズに合わせた革新的な治療法やサービスを開発・販売することで、このトレンドを活かすことができます。
例えば、
- 2022年6月、米国国立医学図書館が発表した論文によると、脊髄損傷（SCI）の発生率と負担は過去30年間で増加しています。男性と高齢者は、女性や若年層よりも大きな影響を受けています。SCIの主な原因は、転倒と交通事故でした。
- 世界保健機関（WHO）が発表した記事によると、2024年4月時点で、世界で1,500万人以上が脊髄損傷（SCI）を抱えて生活しています。SCIの多くは、転倒、交通事故、暴力などの外傷が原因です。
外傷の発生率の上昇は、世界の脊髄損傷（SCI）治療市場の大幅な拡大を促し、様々な医療分野に機会を生み出しています。この患者集団の特定のニーズに合わせた革新的で効果的なソリューションに注力することが不可欠です。高度な治療法の継続的な開発と提供は、高まる需要に応え、脊髄損傷に苦しむ人々の転帰を改善する上で極めて重要です。
人工知能とビッグデータ分析の導入
AIを活用したアルゴリズムと膨大な患者データを活用することで、研究者はこれまで知られていなかったパターンや相関関係を特定し、より効果的な治療戦略や個別化されたケアプランの開発につながります。AIは、治療結果の予測、リハビリテーション計画の最適化、患者ケアプロセスの合理化を支援します。さらに、機械学習アルゴリズムの活用は、高リスク患者の特定、積極的な介入、合併症の発生率の低減に役立ちます。このデータ主導のアプローチは、より正確な診断ツールや予測モデルの開発を促進し、最終的には脊髄損傷（SCI）患者のケアの質の向上につながります。
例えば、
- 2023年4月、国立医学図書館が発表した論文によると、急性脊髄損傷の治療において、生成AIはバイタルサイン、検査結果、その他の患者データを分析することで、褥瘡、尿路感染症、その他の合併症の可能性を予測できるようになる。これにより、臨床医は早期に介入することができ、患者の転帰を改善し、医療費を削減することができる。
- 2023年4月、European Journal of Radiology誌に掲載された論文によると、脊椎における初期のAI応用は、局所病変の評価において顕著な有用性を示している。例えば、一部のアルゴリズムは、通常のMR画像では検出できない脊髄の圧迫性脊髄症の早期変化や脱髄病変を検出できるようになった。
AI主導のインサイトを活用することで、メーカーは個々の患者固有のニーズに応える、より効果的で適応性の高い支援技術を設計・開発できます。さらに、遠隔医療や遠隔モニタリングプラットフォームの活用は患者のエンゲージメントとコンプライアンスの向上につながり、AI搭載のチャットボットやバーチャルアシスタントは患者に24時間365日のサポートとガイダンスを提供できます。脊髄損傷（SCI）治療市場の関係者は、AIとビッグデータ分析を活用することで、患者ケアに革命をもたらし、医療サービスの効率を高め、業界の成長を促進することができます。テクノロジーとヘルスケアの融合は、より効果的な治療法の創出、患者アウトカムの改善、そしてよりパーソナライズされた脊髄損傷（SCI）ケアへのアプローチにつながる可能性があります。
欧州脊髄損傷治療市場の展望
市場は、種類、傷害の種類、傷害の程度、性別、エンドユーザー、流通チャネルに基づいてセグメント化されています。これらのセグメント間の成長は、業界における成長の少ないセグメントの分析に役立ち、ユーザーに貴重な市場概要と市場洞察を提供し、コア市場アプリケーションを特定するための戦略的意思決定を支援します。
タイプ
- 非手術的管理
- 治療
- リハビリテーション療法
- 物理的な
- 作業療法または言語療法
- 脊髄内バクロフェン療法（IBT）
- リハビリテーション療法
- 薬
- 抗けいれん薬
- コルチコステロイド
- メチルプレドニゾロン
- デキサメタゾン
- 抗うつ薬
- SSRI（選択的セロトニン再取り込み阻害薬）
- SNRIS（セロトニンおよびノルエピネフリン再取り込み阻害剤）
- 三環系薬剤
- 不安障害の薬
- 鎮痙薬と筋弛緩薬
- ベンゾジアゼピン
- アルファ2作動薬
- その他のGABA作動薬
- その他
- NSAIDs
- イブプロフェン
- ナプロキセン
- その他
- 麻薬性鎮痛剤
- 抗生物質
- β-ラクタム（ペニシリン、セファロスポリン）
- マクロライド系薬剤（アジスロマイシン、エリスロマイシン）
- ミノサイクリン（テトラサイクリン系）
- ダプソン
- その他（フルオロキノロン、アミノグリコシドなど）
- 治療
- 薬剤の種類別
- ジェネリック
- ブランド
- メドロール
- リオレサル
- リリカ
- ニューロンチン
- ザナフレックス
- グラリス
- ホリザント
- リルテック
- 投与経路別
- オーラル
- タブレット
- カプセル
- 非経口
- 経皮パッチ
- 運用管理
- 減圧手術
- 椎間板切除術または微小椎間板切除術
- 椎弓切除術
- 後方微小椎間板切除術/微小減圧術
- 孔切除術
- 脊椎再建手術
- 後頸椎椎弓切除術
- 椎弓切開術
- 椎間板置換術
- 人工頸椎椎間板移植
- 人工椎間板手術／脊椎関節形成術
- 椎間板および関節面の除去
- 頸椎前方椎間板切除術
- 脊椎固定術
- 腰椎固定術
- 頸椎固定術
- 六分儀融合
- 内側椎間関節切除術
- 2つのファセットジョイントを除去
- 1つの関節面を除去
- その他
- 減圧手術
傷害の種類
- 完全脊髄損傷
- 部分的脊髄損傷
負傷レベル
- 頸髄損傷
- 完全脊髄損傷
- 部分的脊髄損傷
- 胸部脊髄損傷
- 完全脊髄損傷
- 部分的脊髄損傷
- 腰椎脊髄損傷
- 完全脊髄損傷
- 部分的脊髄損傷
- 仙骨脊髄損傷
- 完全脊髄損傷
- 部分的脊髄損傷
性別
- 男
- アダルト
- 老年
- 子供たち
- 女性
- アダルト
- 老年
- 子供たち
エンドユーザー
- 病院
- 外傷センター
- 専門クリニック
- クリニック
- 外来・研究センター
- その他
流通チャネル
- 病院薬局
- 小売薬局
- オンライン薬局
欧州脊髄損傷治療市場地域分析
市場は分析され、市場規模の洞察と傾向は、上記のように国、タイプ、傷害の種類、傷害のレベル、性別、エンドユーザー、流通チャネル別に提供されます。
市場対象となる国は、ドイツ、フランス、イギリス、オランダ、スイス、ベルギー、ロシア、イタリア、スペイン、トルコ、およびその他のヨーロッパ諸国です。
ドイツは、先進的な医療インフラ、強力な研究能力、医療技術への多額の投資により、ヨーロッパの脊髄損傷治療市場を支配すると予想されています。
ドイツは、脊髄損傷の罹患率の増加、老年人口の増加、革新的な治療オプションの進歩により、脊髄損傷治療市場において最も高い CAGR を達成すると予想されています。
本レポートの国別セクションでは、市場の現在および将来の動向に影響を与える、各国の市場に影響を与える要因や国内市場における規制の変更についても解説しています。下流および上流のバリューチェーン分析、技術トレンド、ポーターのファイブフォース分析、ケーススタディといったデータポイントは、各国の市場シナリオを予測するための指標として活用されています。また、ヨーロッパブランドの存在と入手可能性、そして現地および国内ブランドとの競争の激しさや希少性によって直面する課題、国内関税や貿易ルートの影響についても、国別データの予測分析において考慮されています。
欧州脊髄損傷治療市場シェア
市場競争環境は、競合他社ごとに詳細な情報を提供します。企業概要、財務状況、収益、市場ポテンシャル、研究開発投資、新規市場への取り組み、欧州におけるプレゼンス、生産拠点・設備、生産能力、強みと弱み、製品投入、製品群の幅広さ、アプリケーションにおける優位性などの詳細が含まれます。上記のデータは、各社の市場への注力分野にのみ関連しています。
欧州脊髄損傷治療市場 において、市場リーダーとして活躍する企業は以下の通りです。
- ノバルティスAG（スイス）
- ファイザー社（米国）
- メドトロニック（アイルランド）
- ジマー・バイオメット（米国）
- アボット（米国）
- アムニール・ファーマシューティカルズLLC（米国）
- サノフィ（フランス）
- アクソニス・セラピューティクス（米国）
- ザイダスグループ（インド）
- リネージセルセラピューティクス社（米国）
- サン・ファーマシューティカル・インダストリーズ（インド）
- キャンバー・ファーマシューティカルズ社（米国）
- ドクター・レディーズ・ラボラトリーズ社（インド）
- テバ・ファーマシューティカルズUS社（イスラエル）
- ニクサン・ファーマシューティカルズ（インド）
- Covis Pharma GmbH（スイス）
- インド脊髄損傷センター（インド）
- ジュビラント・カディスタ・ファーマシューティカルズ社（米国）
- ジョンソン・エンド・ジョンソン（米国）
- ナーヴジェン・ファーマ・コーポレーション（カナダ）
- アドバケア・ファーマ（米国）
- ボストン・サイエンティフィック（米国）
- ヴァスダ・ファーマ（インド）
- エノマーク（インド）
- グレンマーク・ファーマシューティカルズUS社（米国）
- イノバ・ファーマシューティカルズ（オーストラリア）
- グローバス・メディカル（米国）
- Zimvie Inc.（米国）
- バイオアキソン（カナダ）
欧州脊髄損傷治療市場の最新動向
- 2023年5月、アボットは、FDAが、非外科的腰痛として知られる、腰部手術を受けていない、または受ける資格のない人の慢性腰痛の治療薬として、脊髄刺激（SCS）デバイスを承認したと発表しました。
- 2025年1月、アボットは、同社独自の脊髄刺激（SCS）技術であるBurstDRが、慢性疼痛、特に腰痛や脚の痛みに悩む人々に長期的かつ持続的な緩和効果をもたらすことを示す新たな4年間のデータを発表しました。このデータは、患者が治療に高い満足度を示していることを裏付けるものであり、複数年にわたる追跡調査の4年目の成果を表しており、フロリダ州オーランドで開催される北米神経調節（NANS）2025年次総会で発表されます。
- 2024年8月、ジンマー・バイオメットはOrthoGrid Systemsの買収契約を締結し、OrthoGridのAI駆動型Hip AI手術ガイダンスプラットフォームを導入することで股関節ポートフォリオを拡大しました。この買収には、AIを活用した透視ベースのシステムが含まれており、手術の精度と効率性を向上させます。
- 2020年12月、キャンバー・ファーマシューティカルズはリオレサールのジェネリック医薬品であるバクロフェン錠を発売しました。バクロフェンは、多発性硬化症や脊髄損傷などの症状における筋肉痛、けいれん、こわばりの治療に用いられます。10mgと20mgの2種類の用量があり、筋肉を弛緩させ、不快感を和らげることで、これらの症状の緩和をもたらします。
- 2020年12月、Globus Medicalは、米国の大手グループ購買組織であるPremierとのグループ購買契約を締結したことを発表しました。この契約により、市場での信頼性が高まり、将来の収益増加につながります。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE SPINAL CORD INJURY TREATMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 EUROPE SPINAL CORD INJURY TREATMENT MARKET: REGULATIONS
5.1 ONGOING COMPLIANCE AND UPDATES:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING COLLABORATION AND EXPANDING PARTNERSHIPS
6.1.2 TECHNOLOGICAL ADVANCEMENTS IN TREATMENT METHODS
6.1.3 INCREASING HEALTHCARE EXPENDITURE
6.1.4 ENHANCED REHABILITATION TECHNIQUES
6.2 RESTRAINTS
6.2.1 POTENTIAL RISKS, SIDE EFFECTS, AND COMPLICATIONS OF SPINAL CORD TREATMENTS
6.2.2 REGULATORY BARRIERS LIMIT MARKET GROWTH BY DELAYING TREATMENT APPROVALS AND ACCESSIBILITY
6.3 OPPORTUNITIES
6.3.1 RISING GERIATRIC POPULATION
6.3.2 RISING INCIDENCE OF TRAUMATIC INJURIES
6.3.3 INCORPORATION OF ARTIFICIAL INTELLIGENCE AND BIG DATA ANALYTICS
6.4 CHALLENGES
6.4.1 LIMITED UNDERSTANDING RELATED TO SPINAL CORD INJURY TREATMENTS
6.4.2 HIGH COSTS ASSOCIATED WITH THE TREATMENTS
7 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY TYPE
7.1 OVERVIEW
7.2 NON-OPERATIVE MANAGEMENT
7.2.1 THERAPY
7.2.1.1 Rehabilitation Therapy
7.2.1.1.1 PHYSICAL
7.2.1.1.2 OCCUPATIONAL OR SPEECH THERAPY
7.2.1.2 INTRATHECAL BACLOFEN THERAPY (IBT)
7.2.2 MEDICATION
7.2.2.1 ANTICONVULSANTS
7.2.2.1.1 Pregabalin
7.2.2.1.2 Gabapentin
7.2.2.1.3 Others
7.2.2.2 CORTICOSTEROIDS
7.2.2.2.1 Methylprednisolone
7.2.2.2.2 Dexamethasone
7.2.2.3 ANTIDEPRESSANTS
7.2.2.3.1 SSRIs (Selective Serotonin Reuptake Inhibitors)
7.2.2.3.2 SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors)
7.2.2.3.3 Tricyclic Drugs
7.2.2.3.4 Anxiety Medications
7.2.2.4 ANTISPASMODICS AND MUSCLE RELAXANTS
7.2.2.4.1 Benzodiazepines
7.2.2.4.2 Alpha-2 Agonists
7.2.2.4.3 Other GABA Agonists
7.2.2.4.4 Others
7.2.2.5 NSAIDS
7.2.2.5.1 Ibuprofen
7.2.2.5.2 Naproxen
7.2.2.5.3 Others
7.2.2.6 NARCOTIC ANALGESICS
7.2.2.7 ANTIBIOTICS
7.2.2.7.1 β-Lactams (Penicillins, Cephalosporins)
7.2.2.7.2 Macrolides (Azithromycin, Erythromycin)
7.2.2.7.3 Minocycline (Tetracycline Type)
7.2.2.7.4 Dapsone
7.2.2.7.5 Others (Fluoroquinolones, Aminoglycosides, etc.)
7.2.2.8 Medrol
7.2.2.9 Lioresal
7.2.2.10 Lyrica
7.2.2.11 Neurontin
7.2.2.12 Zanaflex
7.2.2.13 Gralise
7.2.2.14 Rilutek
7.3 OPERATIVE MANAGEMENT
7.3.1 DECOMPRESSION SURGERY
7.3.1.1 Discectomy Or Microdiscectomy
7.3.1.2 Laminectomy
7.3.1.3 Posterior Microdiscectomy/ Microdecompression
7.3.1.4 Foraminectomy
7.3.1.5 Reconstructive Spinal Surgery
7.3.1.6 Posterior Cervical Laminectomy
7.3.1.7 Laminotomy
7.3.2 DISC REPLACEMENT
7.3.2.1 Artificial Cervical Disc Implantation
7.3.2.2 Artificial Disc Surgery/ Spinal Arthroplasty
7.3.3 DISC AND FACET JOINT REMOVAL
7.3.3.1 Anterior Cervical Discectomy
7.3.3.2 Spinal Fusion
7.3.3.2.1 Lumbar Spinal Fusion
7.3.3.2.2 Cervical Spinal Fusion
7.3.3.2.3 Sextant Fusion
7.3.3.3 Medial Facetectomy
7.3.3.3.1 REMOVE TWO FACET JOINT
7.3.3.3.2 REMOVE ONE FACET JOINT
8 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY
8.1 OVERVIEW
8.2 CERVICAL SPINAL CORD INJURIES
8.2.1 COMPLETE SPINAL CORD INJURIES
8.2.2 PARTIAL SPINAL CORD INJURIES
8.3 THORACIC SPINAL CORD INJURIES
8.3.1 COMPLETE SPINAL CORD INJURIES
8.3.2 PARTIAL SPINAL CORD INJURIES
8.4 LUMBAR SPINAL CORD INJURIES
8.4.1 COMPLETE SPINAL CORD INJURIES
8.4.2 PARTIAL SPINAL CORD INJURIES
8.5 SACRAL SPINAL CORD INJURIES
8.5.1 COMPLETE SPINAL CORD INJURIES
8.5.2 PARTIAL SPINAL CORD INJURIES
9 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE
9.1 OVERVIEW
9.2 COMPLETE SPINAL CORD INJURIES
9.3 PARTIAL SPINAL CORD INJURIES
10 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY GENDER
10.1 OVERVIEW
10.2 MALE
10.2.1 ADULT
10.2.2 GERIATIC
10.2.3 CHILDREN
10.3 FEMALE
10.3.1 ADULT
10.3.2 GERIATIC
10.3.3 CHILDREN
11 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 TRAUMA CENTERS
11.4 SPECIALTY CLINICS
11.5 CLINICS
11.6 AMBULATORY AND RESEARCH CENTERS
11.7 OTHERS
12 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY REGION
12.1 EUROPE
12.1.1 GERMANY
12.1.2 U.K.
12.1.3 FRANCE
12.1.4 ITALY
12.1.5 SPAIN
12.1.6 RUSSIA
12.1.7 NETHERLANDS
12.1.8 SWITZERLAND
12.1.9 TURKEY
12.1.10 AUSTRIA
12.1.11 POLAND
12.1.12 NORWAY
12.1.13 IRELAND
12.1.14 FINLAND
12.1.15 SWEDEN
12.1.16 REST OF EUROPE
13 EUROPE SPINAL CORD INJURY TREATMENT MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 PFIZER INC.
15.1.1 COMPANY SHARE ANALYSIS
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 ABBOTT
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 MEDTRONIC
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 NOVARTIS AG
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 ZIMMER BIOMET
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 AMNEAL PHARMACEUTICALS LLC
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 AXONIS THERAPEUTICS
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 ADVACARE PHARMA
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 BIOAXONE BIOSCIENCES
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 BOSTON SCIENTIFIC CORPORATION
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 COVIS PHARMA GMBH.
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 CAMBER PHARMACEUTICALS, INC
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 DR. REDDY’S LABORATORIES LTD
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENT
15.14 ENOMARK PHARMA
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 GLENMARK PHARMACEUTICALS INC.,
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENT
15.16 GLOBUS MEDICAL
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENTS/NEWS
15.17 INOVA PHARMACEUTICALS
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 INDIAN SPINAL INJURIES CENTRE
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.19 JUBILANT CADISTA PHARMACEUTICALS INC.
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
15.2 JOHNSON & JOHNSON SERVICES, INC
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENTS
15.21 LINEAGE CELL THERAPEUTICS, INC.
15.21.1 COMPANY SNAPSHOT
15.21.2 ANNUAL REVENUE
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENT
15.22 NERVGEN PHARMA CORP.
15.22.1 COMPANY SNAPSHOT
15.22.2 REVENUE ANALYSIS
15.22.3 PRODUCT PIPELINE PORTFOLIO
15.22.4 RECENT DEVELOPMENT
15.23 NIKSAN PHARMACEUTICAL
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENT
15.24 SUN PHARMACEUTICAL INDUSTRIES LTD.
15.24.1 COMPANY SNAPSHOT
15.24.2 REVENUE ANALYSIS
15.24.3 PRODUCT PORTFOLIO
15.24.4 RECENT DEVELOPMENT
15.25 SANOFI
15.25.1 COMPANY SNAPSHOT
15.25.2 REVENUE ANALYSIS
15.25.3 PRODUCT PORTFOLIO
15.25.4 RECENT DEVELOPMENT
15.26 TEVA PHARMACEUTICALS USA, INC.
15.26.1 COMPANY SNAPSHOT
15.26.2 REVENUE ANALYSIS
15.26.3 PRODUCT PORTFOLIO
15.26.4 RECENT DEVELOPMENT
15.27 VASUDHA PHARMA
15.27.1 COMPANY SNAPSHOT
15.27.2 PRODUCT PORTFOLIO
15.27.3 RECENT DEVELOPMENT
15.28 ZIMVIE INC.
15.28.1 COMPANY SNAPSHOT
15.28.2 REVENUE ANALYSIS
15.28.3 PRODUCT PORTFOLIO
15.28.4 RECENT NEWS
15.29 ZYDUS GROUP
15.29.1 COMPANY SNAPSHOT
15.29.2 REVENUE ANALYSIS
15.29.3 PRODUCT PORTFOLIO
15.29.4 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
表のリスト
TABLE 1 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 2 EUROPE NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 3 EUROPE NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 4 EUROPE THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 5 EUROPE REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 6 EUROPE MEDICATION IN SPINAL CORD INJURY TREATMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 7 EUROPE ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 EUROPE ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 9 EUROPE ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 10 EUROPE CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 11 EUROPE CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 12 EUROPE CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 13 EUROPE ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 14 EUROPE ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 15 EUROPE ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 16 EUROPE ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE 2018-2032 (USD THOUSAND)
TABLE 17 EUROPE ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 18 EUROPE ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 19 EUROPE NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 20 EUROPE NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 21 EUROPE NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 22 EUROPE ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 23 EUROPE ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 24 EUROPE ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 25 EUROPE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 26 EUROPE BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 27 EUROPE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 28 EUROPE ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 29 EUROPE OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 30 EUROPE OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 31 EUROPE DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 32 EUROPE DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 33 EUROPE DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 34 EUROPE SPINAL FUSION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 35 EUROPE MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE 2018-2032 (USD THOUSAND)
TABLE 36 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 37 EUROPE CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 38 EUROPE CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 39 EUROPE THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 40 EUROPE THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 41 EUROPE LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 42 EUROPE LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 43 EUROPE SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 44 EUROPE SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 45 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 46 EUROPE COMPLETE SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 47 EUROPE PARTIAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 48 EUROPE SPINAL CORD INJURY TREA TMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 49 EUROPE MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 50 EUROPE MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 51 EUROPE FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 52 EUROPE FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 53 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 54 EUROPE HOSPITALS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 55 EUROPE TRAUMA CENTERS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 56 EUROPE SPECIALITY CLINICS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 57 EUROPE CLINICS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 58 EUROPE AMBULATORY AND RESEARCH CENTERS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 59 EUROPE OTHERS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 60 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 61 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 62 EUROPE NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 63 EUROPE THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 64 EUROPE REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 65 EUROPE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 66 EUROPE ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 67 EUROPE ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 68 EUROPE ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 69 EUROPE CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 70 EUROPE CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 71 EUROPE CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 72 EUROPE ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 73 EUROPE ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 74 EUROPE ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 75 EUROPE ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 76 EUROPE ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 77 EUROPE ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 78 EUROPE NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 79 EUROPE NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 80 EUROPE NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 81 EUROPE ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 82 EUROPE ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 83 EUROPE ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 84 EUROPE OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 85 EUROPE DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 86 EUROPE DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 87 EUROPE DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 88 EUROPE SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 EUROPE MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 90 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 91 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 92 EUROPE CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 93 EUROPE THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 94 EUROPE LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 95 EUROPE SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 96 EUROPE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 EUROPE BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 98 EUROPE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 99 EUROPE ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 100 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 101 EUROPE MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 102 EUROPE FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 103 EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 104 EUROPE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 105 GERMANY SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 106 GERMANY NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 GERMANY THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 108 GERMANY REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 109 GERMANY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 110 GERMANY ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 GERMANY ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 112 GERMANY ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 113 GERMANY CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 114 GERMANY CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 115 GERMANY CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 116 GERMANY ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 117 GERMANY ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 118 GERMANY ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 119 GERMANY ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 120 GERMANY ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 121 GERMANY ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 122 GERMANY NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 123 GERMANY NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 124 GERMANY NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 125 GERMANY ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 126 GERMANY ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 127 GERMANY ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 128 GERMANY OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 129 GERMANY DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 130 GERMANY DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 131 GERMANY DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 132 GERMANY SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 133 GERMANY MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 GERMANY SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 135 GERMANY SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 136 GERMANY CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 137 GERMANY THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 138 GERMANY LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 139 GERMANY SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 140 GERMANY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 141 GERMANY BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 142 GERMANY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 143 GERMANY ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 144 GERMANY SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 145 GERMANY MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 146 GERMANY FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 147 GERMANY SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 148 GERMANY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 149 U.K. SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 150 U.K. NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 151 U.K. THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 152 U.K. REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 U.K. MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 154 U.K. ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 155 U.K. ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 156 U.K. ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 157 U.K. CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 158 U.K. CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 159 U.K. CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 160 U.K. ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 161 U.K. ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 162 U.K. ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 163 U.K. ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 164 U.K. ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 165 U.K. ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 166 U.K. NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 167 U.K. NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 168 U.K. NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 169 U.K. ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 170 U.K. ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 171 U.K. ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 172 U.K. OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 173 U.K. DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 174 U.K. DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 175 U.K. DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 176 U.K. SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 177 U.K. MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 178 U.K. SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 179 U.K. SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 180 U.K. CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 181 U.K. THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 182 U.K. LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 183 U.K. SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 184 U.K. MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 185 U.K. BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 186 U.K. MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 187 U.K. ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 188 U.K. SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 189 U.K. MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 190 U.K. FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 191 U.K. SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 192 U.K. MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 193 FRANCE SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 194 FRANCE NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 195 FRANCE THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 196 FRANCE REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 197 FRANCE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 198 FRANCE ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 199 FRANCE ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 200 FRANCE ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 201 FRANCE CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 202 FRANCE CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 203 FRANCE CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 204 FRANCE ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 205 FRANCE ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 206 FRANCE ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 207 FRANCE ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 208 FRANCE ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 209 FRANCE ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 210 FRANCE NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 211 FRANCE NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 212 FRANCE NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 213 FRANCE ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 214 FRANCE ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 215 FRANCE ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 216 FRANCE OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 217 FRANCE DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 218 FRANCE DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 219 FRANCE DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 220 FRANCE SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 221 FRANCE MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 222 FRANCE SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 223 FRANCE SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 224 FRANCE CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 225 FRANCE THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 226 FRANCE LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 227 FRANCE SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 228 FRANCE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 229 FRANCE BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 230 FRANCE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 231 FRANCE ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 232 FRANCE SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 233 FRANCE MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 234 FRANCE FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 235 FRANCE SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 236 FRANCE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 237 ITALY SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 238 ITALY NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 239 ITALY THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 240 ITALY REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 241 ITALY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 242 ITALY ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 243 ITALY ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 244 ITALY ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 245 ITALY CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 246 ITALY CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 247 ITALY CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 248 ITALY ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 249 ITALY ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 250 ITALY ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 251 ITALY ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 252 ITALY ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 253 ITALY ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 254 ITALY NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 255 ITALY NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 256 ITALY NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 257 ITALY ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 258 ITALY ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 259 ITALY ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 260 ITALY OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 261 ITALY DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 262 ITALY DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 263 ITALY DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 264 ITALY SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 265 ITALY MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 266 ITALY SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 267 ITALY SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 268 ITALY CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 269 ITALY THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 270 ITALY LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 271 ITALY SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 272 ITALY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 273 ITALY BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 274 ITALY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 275 ITALY ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 276 ITALY SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 277 ITALY MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 278 ITALY FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 279 ITALY SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 280 ITALY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 281 SPAIN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 282 SPAIN NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 283 SPAIN THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 284 SPAIN REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 285 SPAIN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 286 SPAIN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 287 SPAIN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 288 SPAIN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 289 SPAIN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 290 SPAIN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 291 SPAIN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 292 SPAIN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 293 SPAIN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 294 SPAIN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 295 SPAIN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 296 SPAIN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 297 SPAIN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 298 SPAIN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 299 SPAIN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 300 SPAIN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 301 SPAIN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 302 SPAIN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 303 SPAIN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 304 SPAIN OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 305 SPAIN DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 306 SPAIN DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 307 SPAIN DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 308 SPAIN SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 309 SPAIN MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 310 SPAIN SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 311 SPAIN SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 312 SPAIN CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 313 SPAIN THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 314 SPAIN LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 315 SPAIN SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 316 SPAIN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 317 SPAIN BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 318 SPAIN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 319 SPAIN ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 320 SPAIN SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 321 SPAIN MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 322 SPAIN FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 323 SPAIN SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 324 SPAIN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 325 RUSSIA SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 326 RUSSIA NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 RUSSIA THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 328 RUSSIA REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 329 RUSSIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 330 RUSSIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 331 RUSSIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 332 RUSSIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 333 RUSSIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 334 RUSSIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 335 RUSSIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 336 RUSSIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 337 RUSSIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 338 RUSSIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 339 RUSSIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 340 RUSSIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 341 RUSSIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 342 RUSSIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 343 RUSSIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 344 RUSSIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 345 RUSSIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 346 RUSSIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 347 RUSSIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 348 RUSSIA OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 349 RUSSIA DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 350 RUSSIA DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 351 RUSSIA DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 352 RUSSIA SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 353 RUSSIA MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 354 RUSSIA SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 355 RUSSIA SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 356 RUSSIA CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 357 RUSSIA THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 358 RUSSIA LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 359 RUSSIA SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 360 RUSSIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 361 RUSSIA BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 362 RUSSIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 363 RUSSIA ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 364 RUSSIA SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 365 RUSSIA MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 366 RUSSIA FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 367 RUSSIA SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 368 RUSSIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 369 NETHERLANDS SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 370 NETHERLANDS NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 371 NETHERLANDS THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 372 NETHERLANDS REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 373 NETHERLANDS MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 374 NETHERLANDS ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 375 NETHERLANDS ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 376 NETHERLANDS ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 377 NETHERLANDS CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 378 NETHERLANDS CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 379 NETHERLANDS CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 380 NETHERLANDS ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 381 NETHERLANDS ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 382 NETHERLANDS ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 383 NETHERLANDS ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 384 NETHERLANDS ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 385 NETHERLANDS ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 386 NETHERLANDS NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 387 NETHERLANDS NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 388 NETHERLANDS NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 389 NETHERLANDS ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 390 NETHERLANDS ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 391 NETHERLANDS ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 392 NETHERLANDS OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 393 NETHERLANDS DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 394 NETHERLANDS DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 395 NETHERLANDS DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 396 NETHERLANDS SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 397 NETHERLANDS MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 398 NETHERLANDS SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 399 NETHERLANDS SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 400 NETHERLANDS CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 401 NETHERLANDS THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 402 NETHERLANDS LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 403 NETHERLANDS SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 404 NETHERLANDS MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 405 NETHERLANDS BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 406 NETHERLANDS MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 407 NETHERLANDS ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 408 NETHERLANDS SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 409 NETHERLANDS MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 410 NETHERLANDS FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 411 NETHERLANDS SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 412 NETHERLANDS MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 413 SWITZERLAND SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 414 SWITZERLAND NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 415 SWITZERLAND THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 416 SWITZERLAND REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 417 SWITZERLAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 418 SWITZERLAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 419 SWITZERLAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 420 SWITZERLAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 421 SWITZERLAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 422 SWITZERLAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 423 SWITZERLAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 424 SWITZERLAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 425 SWITZERLAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 426 SWITZERLAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 427 SWITZERLAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 428 SWITZERLAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 429 SWITZERLAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 430 SWITZERLAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 431 SWITZERLAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 432 SWITZERLAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 433 SWITZERLAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 434 SWITZERLAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 435 SWITZERLAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 436 SWITZERLAND OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 437 SWITZERLAND DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 438 SWITZERLAND DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 439 SWITZERLAND DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 440 SWITZERLAND SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 441 SWITZERLAND MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 442 SWITZERLAND SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 443 SWITZERLAND SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 444 SWITZERLAND CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 445 SWITZERLAND THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 446 SWITZERLAND LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 447 SWITZERLAND SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 448 SWITZERLAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 449 SWITZERLAND BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 450 SWITZERLAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 451 SWITZERLAND ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 452 SWITZERLAND SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 453 SWITZERLAND MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 454 SWITZERLAND FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 455 SWITZERLAND SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 456 SWITZERLAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 457 TURKEY SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 458 TURKEY NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 459 TURKEY THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 460 TURKEY REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 461 TURKEY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 462 TURKEY ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 463 TURKEY ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 464 TURKEY ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 465 TURKEY CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 466 TURKEY CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 467 TURKEY CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 468 TURKEY ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 469 TURKEY ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 470 TURKEY ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 471 TURKEY ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 472 TURKEY ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 473 TURKEY ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 474 TURKEY NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 475 TURKEY NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 476 TURKEY NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 477 TURKEY ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 478 TURKEY ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 479 TURKEY ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 480 TURKEY OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 481 TURKEY DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 482 TURKEY DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 483 TURKEY DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 484 TURKEY SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 485 TURKEY MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 486 TURKEY SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 487 TURKEY SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 488 TURKEY CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 489 TURKEY THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 490 TURKEY LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 491 TURKEY SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 492 TURKEY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 493 TURKEY BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 494 TURKEY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 495 TURKEY ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 496 TURKEY SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 497 TURKEY MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 498 TURKEY FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 499 TURKEY SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 500 TURKEY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 501 AUSTRIA SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 502 AUSTRIA NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 503 AUSTRIA THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 504 AUSTRIA REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 505 AUSTRIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 506 AUSTRIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 507 AUSTRIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 508 AUSTRIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 509 AUSTRIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 510 AUSTRIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 511 AUSTRIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 512 AUSTRIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 513 AUSTRIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 514 AUSTRIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 515 AUSTRIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 516 AUSTRIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 517 AUSTRIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 518 AUSTRIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 519 AUSTRIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 520 AUSTRIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 521 AUSTRIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 522 AUSTRIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 523 AUSTRIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 524 AUSTRIA OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 525 AUSTRIA DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 526 AUSTRIA DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 527 AUSTRIA DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 528 AUSTRIA SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 529 AUSTRIA MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 530 AUSTRIA SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 531 AUSTRIA SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 532 AUSTRIA CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 533 AUSTRIA THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 534 AUSTRIA LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 535 AUSTRIA SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 536 AUSTRIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 537 AUSTRIA BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 538 AUSTRIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 539 AUSTRIA ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 540 AUSTRIA SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 541 AUSTRIA MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 542 AUSTRIA FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 543 AUSTRIA SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 544 AUSTRIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 545 POLAND SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 546 POLAND NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 547 POLAND THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 548 POLAND REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 549 POLAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 550 POLAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 551 POLAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 552 POLAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 553 POLAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 554 POLAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 555 POLAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 556 POLAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 557 POLAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 558 POLAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 559 POLAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 560 POLAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 561 POLAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 562 POLAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 563 POLAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 564 POLAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 565 POLAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 566 POLAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 567 POLAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 568 POLAND OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 569 POLAND DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 570 POLAND DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 571 POLAND DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 572 POLAND SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 573 POLAND MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 574 POLAND SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 575 POLAND SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 576 POLAND CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 577 POLAND THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 578 POLAND LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 579 POLAND SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 580 POLAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 581 POLAND BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 582 POLAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 583 POLAND ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 584 POLAND SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 585 POLAND MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 586 POLAND FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 587 POLAND SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 588 POLAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 589 NORWAY SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 590 NORWAY NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 591 NORWAY THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 592 NORWAY REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 593 NORWAY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 594 NORWAY ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 595 NORWAY ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 596 NORWAY ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 597 NORWAY CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 598 NORWAY CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 599 NORWAY CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 600 NORWAY ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 601 NORWAY ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 602 NORWAY ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 603 NORWAY ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 604 NORWAY ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 605 NORWAY ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 606 NORWAY NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 607 NORWAY NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 608 NORWAY NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 609 NORWAY ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 610 NORWAY ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 611 NORWAY ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 612 NORWAY OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 613 NORWAY DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 614 NORWAY DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 615 NORWAY DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 616 NORWAY SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 617 NORWAY MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 618 NORWAY SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 619 NORWAY SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 620 NORWAY CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 621 NORWAY THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 622 NORWAY LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 623 NORWAY SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 624 NORWAY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 625 NORWAY BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 626 NORWAY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 627 NORWAY ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 628 NORWAY SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 629 NORWAY MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 630 NORWAY FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 631 NORWAY SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 632 NORWAY MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 633 IRELAND SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 634 IRELAND NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 635 IRELAND THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 636 IRELAND REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 637 IRELAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 638 IRELAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 639 IRELAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 640 IRELAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 641 IRELAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 642 IRELAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 643 IRELAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 644 IRELAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 645 IRELAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 646 IRELAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 647 IRELAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 648 IRELAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 649 IRELAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 650 IRELAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 651 IRELAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 652 IRELAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 653 IRELAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 654 IRELAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 655 IRELAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 656 IRELAND OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 657 IRELAND DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 658 IRELAND DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 659 IRELAND DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 660 IRELAND SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 661 IRELAND MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 662 IRELAND SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 663 IRELAND SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 664 IRELAND CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 665 IRELAND THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 666 IRELAND LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 667 IRELAND SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 668 IRELAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 669 IRELAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 670 IRELAND ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 671 IRELAND SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 672 IRELAND MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 673 IRELAND FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 674 IRELAND SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 675 IRELAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 676 FINLAND SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 677 FINLAND NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 678 FINLAND THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 679 FINLAND REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 680 FINLAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 681 FINLAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 682 FINLAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 683 FINLAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 684 FINLAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 685 FINLAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 686 FINLAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 687 FINLAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 688 FINLAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 689 FINLAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 690 FINLAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 691 FINLAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 692 FINLAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 693 FINLAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 694 FINLAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 695 FINLAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 696 FINLAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 697 FINLAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 698 FINLAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 699 FINLAND OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 700 FINLAND DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 701 FINLAND DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 702 FINLAND DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 703 FINLAND SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 704 FINLAND MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 705 FINLAND SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 706 FINLAND SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 707 FINLAND CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 708 FINLAND THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 709 FINLAND LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 710 FINLAND SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 711 FINLAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 712 FINLAND BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 713 FINLAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 714 FINLAND ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 715 FINLAND SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 716 FINLAND MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 717 FINLAND FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 718 FINLAND SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 719 FINLAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 720 SWEDEN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 721 SWEDEN NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 722 SWEDEN THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 723 SWEDEN REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 724 SWEDEN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 725 SWEDEN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 726 SWEDEN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 727 SWEDEN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 728 SWEDEN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 729 SWEDEN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 730 SWEDEN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 731 SWEDEN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 732 SWEDEN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 733 SWEDEN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 734 SWEDEN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 735 SWEDEN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 736 SWEDEN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 737 SWEDEN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 738 SWEDEN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 739 SWEDEN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 740 SWEDEN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 741 SWEDEN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 742 SWEDEN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 743 SWEDEN OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 744 SWEDEN DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 745 SWEDEN DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 746 SWEDEN DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 747 SWEDEN SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 748 SWEDEN MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 749 SWEDEN SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 750 SWEDEN SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 751 SWEDEN CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 752 SWEDEN THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 753 SWEDEN LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 754 SWEDEN SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 755 SWEDEN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 756 SWEDEN BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 757 SWEDEN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 758 SWEDEN ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 759 SWEDEN SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 760 SWEDEN MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 761 SWEDEN FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 762 SWEDEN SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 763 SWEDEN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 764 REST OF EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
図表一覧
FIGURE 1 EUROPE SPINAL CORD INJURY TREATMENT MARKET: SEGMENTATION
FIGURE 2 EUROPE SPINAL CORD INJURY TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE SPINAL CORD INJURY TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 EUROPE SPINAL CORD INJURY TREATMENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE SPINAL CORD INJURY TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE SPINAL CORD INJURY TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE SPINAL CORD INJURY TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE SPINAL CORD INJURY TREATMENT MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 EUROPE SPINAL CORD INJURY TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE SPINAL CORD INJURY TREATMENT MARKET: SEGMENTATION
FIGURE 11 EUROPE SPINAL CORD INJURY TREATMENT MARKET EXECUTIVE SUMMARY
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 TWO SEGMENTS COMPRISE THE EUROPE SPINAL CORD INJURY TREATMENT MARKET, BY TYPE
FIGURE 14 GROWING COLLABORATION AND EXPANDING PARTNERSHIPS IS EXPECTED TO DRIVE THE EUROPE SPINAL CORD INJURY TREATMENT MARKET GROWTH IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 15 NON-OPERATIVE MANAGEMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE SPINAL CORD INJURY TREATMENT IN THE FORECAST PERIOD OF 2025 & 2032
FIGURE 16 MARKET OVERVIEW
FIGURE 17 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY TYPE, 2024
FIGURE 18 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY TYPE, 2025-2032 (USD THOUSAND)
FIGURE 19 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY TYPE, CAGR (2025-2032)
FIGURE 20 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 21 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY LEVEL OF INJURY, 2024
FIGURE 22 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY LEVEL OF INJURY, 2025-2032 (USD THOUSAND)
FIGURE 23 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY LEVEL OF INJURY, CAGR (2025-2032)
FIGURE 24 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY LEVEL OF INJURY, LIFELINE CURVE
FIGURE 25 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY INJURY TYPE, 2024
FIGURE 26 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY INJURY TYPE, 2025-2032 (USD THOUSAND)
FIGURE 27 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY INJURY TYPE, CAGR (2025-2032)
FIGURE 28 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY INJURY TYPE, LIFELINE CURVE
FIGURE 29 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY GENDER, 2024
FIGURE 30 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY GENDER, 2025-2032 (USD THOUSAND)
FIGURE 31 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY GENDER, CAGR (2025-2032)
FIGURE 32 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY GENDER, LIFELINE CURVE
FIGURE 33 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY END USER, 2024
FIGURE 34 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY END USER, 2025-2032 (USD THOUSAND)
FIGURE 35 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY END USER, CAGR (2025-2032)
FIGURE 36 EUROPE SPINAL CORD INJURY TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 37 EUROPE SPINAL CORD INJURY TREATMENT MARKET: SNAPSHOT (2024)
FIGURE 38 EUROPE SPINAL CORD INJURY TREATMENT MARKET: COMPANY SHARE 2024 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
